Form 4: Director Martha Shadan Acquires LMAT Shares

Lemaitre Vascular Director Martha Shadan acquired 10 shares of common stock through the vesting of restricted and performance stock unit awards.

Summary

• Martha Shadan, a Director of Lemaitre Vascular Inc., acquired a total of 10 shares of the company's common stock.
• The acquisitions occurred on December 12, 2025, with each share acquired at a price of $0.
• These shares were obtained through the release of dividend equivalent rights associated with the vesting of a restricted stock unit (RSU) award and a performance stock unit (PSU) award.
• Both the RSU and PSU awards were originally granted on December 12, 2022.
• Following these transactions, Martha Shadan's direct beneficial ownership of Lemaitre Vascular common stock increased from 2,475 shares to 2,485 shares.

Sentiment

Score: 6

Explanation: The filing reports a routine insider acquisition of shares through equity award vesting, which is a neutral to slightly positive event as it increases insider ownership and aligns interests. No significant positive or negative financial or operational news is present.

Positives

• Director Martha Shadan increased her direct beneficial ownership in Lemaitre Vascular Inc. by 10 shares, further aligning her interests with shareholders.
• The vesting of restricted and performance stock units indicates the fulfillment of previously established equity compensation milestones.

Negatives

• No specific negatives are identified in this routine insider transaction filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

This is a routine insider transaction related to equity compensation and does not provide broader industry context or trends. It reflects standard practices for executive and director compensation in publicly traded companies, where equity awards vest over time.

Comparison to Industry Standards

• This filing details a standard equity compensation event (vesting of RSUs/PSUs) for a director. Such compensation structures are common across various industries, including the medical device sector where Lemaitre Vascular operates, to align management and director incentives with long-term shareholder value.
• No specific comparable companies, projects, or results are mentioned in the filing to allow for a detailed comparison.

Related Party Transactions

• The transaction involves a director acquiring shares from the company as part of an equity compensation plan, which is a common form of related party transaction and is routinely disclosed.

Stakeholder Impact

• Shareholders: Slightly positive, as it indicates increased insider ownership, potentially signaling confidence in the company's future.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• No specific future actions, events, or milestones are mentioned beyond the completion of this transaction.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where a director acquired shares through the vesting of equity awards. It does not contain any new material information regarding the company's financial performance, strategic direction, or operational outlook that would warrant a change in investment recommendation. The increase in insider ownership is a minor positive, but insufficient to alter a broader investment thesis. Investors should hold their positions and await more substantive corporate updates.

Keywords

Lemaitre Vascular, LMAT, Martha Shadan, Insider Trading, Form 4, Stock Acquisition, Restricted Stock Units, Performance Stock Units, Director, Equity Compensation